2024 (1 POST)

Schaefer H. Cadmium–Initiatives to reduce dietary exposure. Society for Risk Analysis Annual Meeting, Austin, TX, 2024.

2023 (1 POST)

Schaefer HR, Flannery BM, Crosby LM, Pouillot R, Farakos SMS, Van Doren JM, Dennis S, Fitzpatrick S, Middleton K. 2023. Reassessment of the cadmium toxicological reference value for use in human health assessments of foods. Regul Toxicol Pharmacol 144(Oct):105487; doi: 10.1016/j.yrtph.2023.105487. PMID: 37640100.

View Abstract

2022 (3 POSTS)

Schaefer HR, Flannery BM, Crosby L, Jones-Dominic OE, Punzalan C, Middleton K. 2022. A systematic review of adverse health effects associated with oral cadmium exposure. Regul Toxicol Pharmacol 134(Oct):105243; doi: 10.1016/j.yrtph.2022.105243. PMID: 35981600.

View Abstract

Pouillot R, Farakos SS, Spungen J, Schaefer HR, Flannery BM, Van Doren JM. 2022. Cadmium physiologically based pharmacokinetic (PBPK) models for forward and reverse dosimetry: Review, evaluation, and adaptation to the U.S. population. Toxicol Lett 367(Aug):67-75; doi: 10.1016/j.toxlet.2022.07.812. PMID: 35901988. Corrigendum: Toxicol Lett 2023 377(March):14-15; doi: 10.1016/j.toxlet.2023.01.011.

View Abstract

Flannery BM, Schaefer HR, Middleton KB. 2022. A scoping review of infant and children health effects associated with cadmium exposure. Regul Toxicol Pharmacol 131(Jun):105155; doi: 10.1016/j.yrtph.2022.105155. PMID: 35257832.

View Abstract

2020 (1 POST)

Schaefer HR, Dennis S, Fitzpatrick S. 2020. Cadmium: Mitigation strategies to reduce dietary exposure. J Food Sci 85(2):260-267; doi: 10.1111/1750-3841.14997. PMID: 31957884.

View Abstract